March 8, 2006 | 12 - 1 am

FDA’s Federal Preemption Policy: Implications for Drug Labeling and Product Liability Litigation

Justices’ “CVSG” Signals Interest in Drug Companies’ Challenge to Oregon Compelled Speech Law

Compromise Necessary but Not Sufficient for AI Preemption